| Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer (NCT04553770) | Jonsson Comprehensive Cancer Center | 2020-10-09 |
| Exercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Cancer (NCT03091842) | University of Southern California | 2019-07-29 |
| Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer (NCT03414970) | Alliance for Clinical Trials in Oncology | 2018-03-12 |
| Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer (NCT03345420) | University of Utah | 2017-12-12 |
| Intraoperative Electron Beam Radiotherapy Boost in Treating Patients With Stage I-II Breast Cancer Undergoing Surgery With Reconstruction (NCT02927912) | Ohio State University Comprehensive Cancer Center | 2017-10-16 |
| Aerobic and Strength Training Exercise in Improving Fitness and Arm Health During and After Radiation Therapy in Patients With Stage II-III Breast Cancer (NCT03102866) | Ohio State University Comprehensive Cancer Center | 2017-08-30 |
| Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors (NCT03284346) | University of Southern California | 2017-08-17 |
| Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast Cancer (NCT03128619) | Jonsson Comprehensive Cancer Center | 2017-08-02 |
| Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast Cancer (NCT03139435) | Wake Forest University Health Sciences | 2017-05-11 |
| Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery (NCT03188393) | NRG Oncology | 2017-04-13 |
| Mindfulness Meditation or Survivorship Education in Improving Behavioral Symptoms in Younger Stage 0-III Breast Cancer Survivors (Pathways to Wellness) (NCT03025139) | Jonsson Comprehensive Cancer Center | 2017-02-20 |
| Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgery (NCT02760030) | Ohio State University Comprehensive Cancer Center | 2017-02-16 |
| Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca (NCT02957968) | Virginia Commonwealth University | 2017-01-24 |
| S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER) (NCT02728596) | SWOG Cancer Research Network | 2016-10-07 |
| Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in Remission (NCT02780401) | University of Washington | 2016-09-02 |
| MRI and Cardio-Pulmonary Exercise Testing in Evaluating Exercise Intolerance in Patients With Stage I-III Breast Cancer After Chemotherapy Treatment (NCT02702830) | Wake Forest University Health Sciences | 2016-08-25 |
| Functional Magnetic Resonance Imaging in Assessing Affect Reactivity and Regulation in Patients With Stage 0-III Breast Cancer (NCT03050463) | Stanford University | 2016-08-01 |
| Survivorship Care Plan in Promoting Physical Activity in Breast or Colorectal Cancer Survivors in Wisconsin (NCT02677389) | University of Wisconsin, Madison | 2016-07-01 |
| Computerized Cognitive Retraining in Improving Cognitive Function in Breast Cancer Survivors (NCT02662335) | Fred Hutchinson Cancer Center | 2016-05-01 |
| eHealth Weight Loss Program in African American Breast Cancer Survivors (NCT02699983) | Rutgers, The State University of New Jersey | 2016-01-08 |
| Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy (NCT02445391) | ECOG-ACRIN Cancer Research Group | 2015-10-20 |
| Attitudes, Beliefs, and Preferences of Older Stage I-III Breast Cancer Survivors Towards Physical Activity (NCT02566408) | Case Comprehensive Cancer Center | 2015-10-14 |
| High-Intensity Interval Training for Stage I-III Breast Cancer Patients (NCT02454777) | University of Southern California | 2015-09-29 |
| Web-Based Decision Aid in Improving Informed Decisions in Patients With Stage 0-IIIA Breast Cancer Considering Contralateral Prophylactic Mastectomy (NCT03061175) | Rutgers, The State University of New Jersey | 2015-09-24 |
| Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors (NCT03198286) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2015-08-01 |
| Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer (NCT02488967) | NRG Oncology | 2015-07-26 |
| Cardiac Rehabilitation Program in Improving Cardiorespiratory Fitness in Stage 0-III Breast Cancer Survivors (NCT03039140) | Ohio State University Comprehensive Cancer Center | 2015-05-14 |
| Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast Cancer (NCT02400060) | Ohio State University Comprehensive Cancer Center | 2015-03-26 |
| Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer (NCT02315196) | Rutgers, The State University of New Jersey | 2015-02-25 |
| Effects of Chemotherapy on Intestinal Bacteria in Patients With Newly Diagnosed Breast Cancer (NCT02370277) | University of Southern California | 2014-12-16 |
| KeraStat Skin Therapy in Treating Radiation Dermatitis in Patients With Newly Diagnosed Stage 0-IIIA Breast Cancer (NCT02168179) | Wake Forest University Health Sciences | 2014-12-01 |
| Exercise Intervention in Preventing Breast Cancer Recurrence in Postmenopausal Breast Cancer Survivors (NCT02235051) | City of Hope Medical Center | 2014-09-07 |
| Typhoid Vaccine in Testing Response to Immune Stress in Patients With Stage I-IIIA Breast Cancer (NCT02415387) | Ohio State University Comprehensive Cancer Center | 2014-01-01 |
| Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Prostate Cancer or Stage I-III Colorectal Cancer (NCT03233555) | Rutgers, The State University of New Jersey | 2013-09-03 |
| Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer (NCT01730833) | City of Hope Medical Center | 2013-07-17 |
| Chemotherapy Before Surgery and Tissue Sample Collection in Patients With Stage IIA-IIIC Breast Cancer (NCT01897441) | Albert Einstein College of Medicine | 2013-06-01 |
| Broccoli Sprout Extract in Treating Patients With Breast Cancer (NCT01753908) | Roswell Park Cancer Institute | 2013-05-21 |
| Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors (NCT01849250) | National Cancer Institute (NCI) | 2013-05-01 |
| Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast Cancer (NCT01776008) | National Cancer Institute (NCI) | 2013-01-01 |
| Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer (NCT01750073) | University of Nebraska | 2012-12-07 |
| Questionnaires in Identifying Upper Extremity Function and Quality of Life After Treatment in Patients With Breast Cancer (NCT02370264) | University of Southern California | 2012-10-01 |
| Biomarkers in Tissue Samples From Patients With Newly Diagnosed Breast Cancer Treated With Zoledronic Acid (NCT01409811) | City of Hope Medical Center | 2012-09-14 |
| Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors (NCT01522820) | Roswell Park Cancer Institute | 2012-03-01 |
| Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer (NCT01525966) | City of Hope Medical Center | 2012-02-15 |
| PTX-200, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide in Treating Patients With Stage IIB-IV Breast Cancer (NCT01697293) | Prescient Therapeutics, Ltd. | 2012-01-01 |
| FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer (NCT01928186) | University of Washington | 2011-09-01 |
| MK2206 in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer (NCT01319539) | National Cancer Institute (NCI) | 2011-04-01 |
| Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer (NCT01293032) | Virginia Commonwealth University | 2011-04-01 |
| Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage II or Stage III Triple-Negative Breast Cancer (NCT01238133) | National Cancer Institute (NCI) | 2010-12-01 |
| Phase II Study of Fluorine-18 3'-Deoxy-3'-Fluorothymidine (F-18-FLT) in Invasive Breast Cancer (NCT00572728) | National Cancer Institute (NCI) | 2008-12-01 |
| Pazopanib in Treating Patients With Newly Diagnosed or Locally and/or Regionally Recurrent Breast Cancer That Can Be Removed By Surgery (NCT00450879) | National Cancer Institute (NCI) | 2007-01-01 |
| Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer (NCT00066690) | ETOP IBCSG Partners Foundation | 2003-12-17 |
| A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancer (NCT00378313) | NSABP Foundation Inc | 2001-11-01 |